Related Experiment Video

Updated: Nov 26, 2025

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient
07:16

An Educational Video Demonstration of How to Prone a Critically Ill Intubated Patient

Published on: November 30, 2022

4.0K

Survival in adult inpatients with COVID-19

E Murillo-Zamora1, C M Hernandez-Suarez2

  • 1Departamento de Epidemiología, Unidad de Medicina Familiar No. 19, Instituto Mexicano del Seguro Social, Av. Javier Mina 301, Col. Centro, C.P. 28000, Colima, Colima, México; Facultad de Medicina, Universidad de Colima, Av. Universidad 333, Col. Las Víboras, C.P. 28040, Colima, Colima, México.

Public Health
|December 14, 2020
PubMed

Insights

Survival rates for hospitalized COVID-19 patients decline significantly within 30 days. Male gender, older age, and certain health conditions increase mortality risk, while asthma may offer protection.

Area of Science:

  • Epidemiology
  • Public Health
  • Infectious Diseases

Background:

  • The COVID-19 pandemic has a high mortality rate, with limited data on patient prognosis.
  • Understanding survival trends and risk factors in hospitalized adults is crucial for managing the disease.

Purpose of the Study:

  • To evaluate the survival experience of adult inpatients with laboratory-confirmed COVID-19.
  • To identify factors influencing the prognosis and mortality risk in this patient population.

Main Methods:

  • Nationwide retrospective cohort study involving 66,123 individuals.
  • Kaplan-Meier method used for survival analysis.
  • Multivariate Cox proportional hazard regression model fitted to identify risk factors.

Main Results:

  • Hospitalized patients showed a 7-day survival of 72.2%, decreasing to 23.9% by day 30.
  • Increased mortality risk was associated with male gender, advanced age, pneumonia, immunosuppression, and chronic non-communicable diseases.
  • A history of asthma was linked to a reduced risk of fatal outcomes.

Conclusions:

  • This study represents the largest analysis of COVID-19 survival probability in Latin American adults.
  • Findings enhance the understanding of COVID-19 disease progression and outcomes in a high-burden population.
  • Identified risk and protective factors can inform clinical management and public health strategies.
Abstract

Keywords:
COVID-19Cohort studiesHazards modelsInpatientsProportionalSurvival

More Related Videos

Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit06:52

Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit

Published on: September 30, 2020

10.2K

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
633
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
596
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
306
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
774
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
532